Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 127
- Registration Number
- NCT00901875
- Locations
- 🇨🇳
Chang-Gung Memorial Hospital, Linkou Branch, Gueishan, Taiwan
🇨🇳Chang-Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan
🇨🇳BALI Psychiatric Center, Taipei, Taiwan
A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2016-09-14
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT00838396
Survey of Buprenorphine Use Among "Out of Care" Population in France (P04933)(COMPLETED)
Completed
- Conditions
- Drug Addiction
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT00756353
Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
Completed
- Conditions
- Opioid-Related DisordersDrug AbuseOpiate Dependence
- Interventions
- First Posted Date
- 2008-07-30
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 339
- Registration Number
- NCT00725608
- Locations
- 🇦🇹
(Multiple sites in Austria) => Coordinating CRO: H&P GmbH, Vienna, Austria
Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
Completed
- Conditions
- Opiate-related DisordersOpiate DependenceBuprenorphineNaloxoneDrug Abuse
- Interventions
- First Posted Date
- 2008-07-29
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 1307
- Registration Number
- NCT00723697
Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
Completed
- Conditions
- Opioid-Related DisordersOpiate DependenceDrug Abuse
- Interventions
- First Posted Date
- 2008-07-29
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 384
- Registration Number
- NCT00723749
Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
Phase 4
Completed
- Conditions
- Opiate-related DisordersDrug AbuseOpiate Dependence
- Interventions
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT00684073
Safety and Tolerability of Buprenorphine/Naloxone Film Strips
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- Interventions
- Drug: Buprenorphine/naloxone Film Strip
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2012-11-12
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 382
- Registration Number
- NCT00640835
- Locations
- 🇺🇸
Winston Technology Research LLC, Haleyville, Alabama, United States
🇺🇸Beeches Family Medicine, Jacksonville Beach, Florida, United States
🇺🇸Parkway Medical Center, Birmingham, Alabama, United States
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
Phase 2
Completed
- Conditions
- Opioid-related Disorders
- Interventions
- First Posted Date
- 2008-03-17
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT00637000
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)
Phase 4
Completed
- Conditions
- Drug DependenceOpiate Dependence
- Interventions
- First Posted Date
- 2008-01-30
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 241
- Registration Number
- NCT00605033
© Copyright 2025. All Rights Reserved by MedPath